Bill 250: Colon Cancer Prevention Program Expansion Act

This bill primarily affects the Nova Scotia healthcare sector rather than private businesses directly. Medical clinics, diagnostic imaging centres, and gastroenterology practices in Nova Scotia could see increased patient volumes as more residents become eligible for colon cancer screening. Healthcare supply companies providing colonoscopy equipment, test kits, and related consumables may also experience higher demand. There is minimal direct impact on businesses outside the health services sector, and firm size is less relevant than whether a business operates within Nova Scotia's health delivery ecosystem.